Home
Conditions
Metastatic Ovarian Carcinoma

Clinical trial condition

Metastatic Ovarian Carcinoma

Explore clinical trials studying Metastatic Ovarian Carcinoma. Study availability and eligibility vary by location and protocol.

17 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Ovarian Carcinoma trial results

Recruiting

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

NCT04329494

Conditions: Abdominal Neoplasms, Adnexal Diseases, Appendiceal Neoplasms, +62 more
Locations: City of Hope Medical Center Duarte, California, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Northwell Health Cancer Institute at Huntington Greenlawn, New York, United States

View Trial Details

Recruiting

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

NCT05759923

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Colorectal Carcinoma, +41 more
Locations: Site Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Otwock, Masovian Voivodeship, Poland

SIte Warsaw, Masovian Voivodeship, Poland

View Trial Details

Recruiting

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

NCT05092373

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Breast Carcinoma, +110 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

NCT04811703

Conditions: Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +30 more
Locations: Hôpital Claude Huriez - Chirurgie générale et digestive Lille, France

Hôpital Claude Huriez - Oncologie médicale Lille, France

Hôpital de la Croix-Rousse Lyon, France

Hôpital Lyon Sud - Chirurgie Digestive et Oncologique Pierre-Bénite, France

View Trial Details

Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions: Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations: University of Arkansas Medical School Little Rock, Arkansas, United States

University of California - Los Angeles Los Angeles, California, United States

UCSF San Francisco, California, United States

SCRI at HealthOne Denver, Colorado, United States

View all 19 locations

View Trial Details

Recruiting

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

NCT05733000

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Not yet recruiting

Prediction of Ovarian Cancer Histotypes and Surgical Outcome

NCT07057167

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Not specified

View Trial Details

Active, not recruiting

Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer

NCT04673448

Conditions: Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +53 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, not recruiting

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

NCT04550494

Conditions: Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
Locations: UF Health Cancer Institute - Gainesville Gainesville, Florida, United States

National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States

View Trial Details

Active, not recruiting

Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02627443

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +26 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

UCHealth University of Colorado Hospital Aurora, Colorado, United States

UF Health Cancer Institute - Gainesville Gainesville, Florida, United States

View all 14 locations

View Trial Details

Metastatic Ovarian Carcinoma

Metastatic Ovarian Carcinoma trial results

Related conditions